Navigation Links
Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
Date:5/7/2009

al achieved the primary endpoint of median Time to Last Unformed Stool (TLUS). Median TLUS for patients treated with prulifloxacin was 32.8 hours which was statistically significant compared to the TLUS for placebo with a p-value of less than 0.0001. Prulifloxacin was generally well tolerated and had a similar safety profile compared to placebo. This is the second of two pivotal Phase 3 clinical studies which will be used to support an NDA submission with the U.S. Food and Drug Administration.
  • Raised $32.9 million in gross proceeds through the sale of 3.3 million shares and warrants to purchase 91,533 shares in a registered direct offering in March 2009.
  • Appointed Francois-Xavier Frapaise, M.D., as Senior Vice President and Chief Scientific Officer and Peter E. Grebow, Ph.D., Executive Vice President of Worldwide Technical Operations at Cephalon, Inc. (Nasdaq: CEPH), to the company's Board of Directors.
  • Published in vitro data highlighting the antibacterial activity of prulifloxacin in the peer-reviewed journal Antimicrobial Agents and Chemotherapy.

  • About Optimer Pharmaceuticals

    Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin, formerly known as OPT-80, is the only antibiotic therapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Prulifloxacin is an antibiotic which has completed two Phase 3 clinical trials for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
    2. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
    3. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
    4. Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
    5. First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals GGTI-2418
    6. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals
    7. Idenix Pharmaceuticals Reports First Quarter Financial Results
    8. Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting
    9. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
    10. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
    11. Vanda Pharmaceuticals Reports First Quarter 2009 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/30/2015)... , June 30, 2015  Custom Computer Specialists, ... today that they are silver sponsors of the Primary ... PCDC sponsor, Custom is lending their support of PCDC,s ... communities. Since its founding in 1993, PCDC ... primary care area.  PCDC has financed over 100 completed ...
    (Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... August 14. She has accepted the position of vice president of instruction at ... 17. , “I greatly appreciated the opportunity to lead SIUE during the ...
    (Date:6/29/2015)... ... ... This cutting edge standard making is a madatory tool for use in ... is the world’s first cuvette-shaped, solid-state filter that lets metrologists and quality control personnel ... calibration standards, such as those made from didymium glass were only able to operate ...
    (Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... significant CAGR of around 19% during the forecast period (2015 to 2020). The ... and upsurge in government and corporate funding for R&D. However, lack of adequate ...
    Breaking Biology Technology:Custom Computer Specialists Announces Sponsorship Of The Primary Care Development Corporation's Corporate Circle 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 2FireflySci Releases Spectrophotometer Calibration Standards for NIR Wavelength Accuracy Verification 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5
    ... a developer of natural egg protein products, has added $3 ... the closing of its latest financing round, which began on ... funding, collected from various angel investors, will be used by ... that improve feed efficiency and animal growth in agriculture. ...
    ... were to design a system to encourage investment in ... disproportionate number of American jobs, would you do any ... research and development, which has a track record of ... system to the point that it becomes cumbersome and ...
    ... Third Wave Technologies Inc. , a Madison company that ... analysis applications, has named Kay Napier to its board of ... bring marketing insight to Third Wave, according to president and ... and women's markets in the promotion of products at ...
    Cached Biology Technology:aOva Technologies raises $3 million 2Regulations designed to protect 'the little guy' are crimping job growth 2Regulations designed to protect 'the little guy' are crimping job growth 3Napier joins board of Third Wave Technologies 2
    (Date:6/11/2015)... Va. , June 11, 2015 ... technology, announced today that its IdentityX Mobile Authentication ... (Fast IDentity Online) Alliance is an industry consortium ... open standards for simpler, stronger authentication.  In order ... must pass a rigorous series of tests that ...
    (Date:6/9/2015)... , June 9, 2015   MedNet Solutions ... the entire spectrum of clinical research, will be providing ... technology platform at the 2015 Drug Information Association (DIA) ... on June 15-17.  These presentations will include previews of ... out in the upcoming iMedNet 2015 Feature ...
    (Date:6/8/2015)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer of cell-free ... Cancer Monitoring SM platform will be presented at the ... San Diego, CA on June 11-12 , ... Genomics and Cancer Therapy in Salt Lake ... "We continue to advance our clinical programs and present data ...
    Breaking Biology News(10 mins):Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4
    ... of researchers has received a four-year, $1 million grant ... for biological separations. Led by Ravi Kane, the Merck ... Polytechnic Institute, the group plans to develop nanoscale surfaces ... could eventually lead to more efficient separation tools for ...
    ... has named researchers at Baylor College of Medicine (BCM) ... only recipients of the inaugural Quantum Grant for their ... blood vessels for the treatment of stroke. , The ... of Biomedical Imaging and Bioengineering (NIBIB), part of the ...
    ... responds almost like natural heart muscle ?even though it ... another step closer to the goal of creating replacement ... entirely new heart from just a spoonful of loose ... are reporting significant progress in growing bioengineered heart muscle, ...
    Cached Biology News:Researchers to develop active nanoscale surfaces for biological separations 2First Quantum Grant to fund stem cell repair of damage from stroke 2A new approach to growing heart muscle 2A new approach to growing heart muscle 3A new approach to growing heart muscle 4